Accelerate your Scope 3 reductions with verified CO₂ data

Turn your lactose sourcing into traceable sustainability performance
Copy Of Copy Of Copy Of Shaping The Future Of Pharmaceutical Innovation By Engaging With The Next Generation Of Talent. (Email Header) (4)

Pharmaceutical companies are under growing pressure to demonstrate real, measurable climate progress, yet Scope 3 emissions remain the hardest to tackle. That’s why DFE Pharma has introduced EcoLact 2030, the CO₂ data-verified lactose offering designed to help you confidently report measurable Scope 3 reductions.

What you get: Accelerated 30% CO₂ reduction

1

Guaranteed 30% CO₂ reduction (2021–2030)

2

Verified using primary, farm-level data

3

Annual CO₂ reduction reports — no offsets, no estimates

Unique value-chain transparency

1

Traceable CO₂ data across sourcing and production

2

Granular insights into sustainability interventions

3

Accountability enabled by DFE Pharma’s integrated supply chain

No regulatory complexities

1

Same trusted high-quality brands

2

No change to product characteristics

3

No requalification required

How you benefit

1

Confident, auditable Scope 3 disclosures for CSRD / SBTi / ESG reporting

2

Real, measurable sustainability impact, not just claims

3

Easy adoption: low risk, high return for procurement & quality teams

Get started

Ready to add credible CO₂ data to your lactose sourcing? Download our brochure to learn more or request a sample CO₂ report.

Download Contact

Book a meeting with our team